Stanley Druckenmiller acquired 4.54M Nuvation Bio shares worth $26.3M. That's 0.82% of their equity portfolio (28th largest holding). The investor owns 1.31% of the outstanding Nuvation Bio stock. The stake costed the investor $25.4M, netting the investor a gain of 3.8% so far.